logobest_018

Noteworthy

John Hughes, M.D., has been appointed Deputy Editor of Nicotine and Tobacco Research, one of the few peer-reviewed journals devoted exclusively to the study of nicotine and tobacco.

Andrea Villanti, Ph.D., has been awarded the SRNT 2018 Jarvik-Russell Early Career Award, honoring members early in their careers who have made extraordinary contributions to the field of nicotine and tobacco research.

Allison N. Kurti, Ph.D., joins the VCBH as an assistant professor. Kurti recently completed her postdoc fellowship with VCBH. She was also recently named DAD editorial fellow.


VCBH Research News

Success at the 5th Annual VCBH Conference on Tobacco Regulatory Science

The 5th Annual VCBH Conference, held October 5-6 in Burlington, Vermont, brought together leading tobacco researchers from universities Zellerand medical centers nationwide to share their knowledge on tobacco regulatory science. Keynote speaker, Mitch Zeller, J.D., gave an outstanding presentation outlining the FDA's new plan for nicotine regulation, which has the potential to reduce overall smoking prevalence and improve public health. To view this talk and all others, please click here.

We hope to see you at the 6th Annual VCBH Conference: October 11-12, 2018!

Sigmon_420x2801

Sigmon receives NIDA Grant to Continue Evaluation of Interim Buprenorphine Treatment

Stacey C. Sigmon, Ph.D., received a $3.7 million grant from the National Institute of Drug Abuse (NIDA) to continue the development and evaluation of a novel Interim Buprenorphine Treatment (IBT) that leverages pharmacotherapy, state-of-the-art technology and rigorous methodology to bridge existing delays in treatment access. "In an initial R34 randomized pilot study, we demonstrated reductions in illicit opioid use and risk behaviors among wait listed opioid abusers receiving IBT. This project will seek to replicate those highly promising initial results while simultaneously evaluating generality of our findings to additional rural settings outside of our single University of Vermont academic medical center."

VCBH Director Bestowed National 2017 Mentorship Award by CPDD

Steve CPDD AwardStephen T. Higgins, Ph.D., director of the VCBH, was honored with the 2017 Mentorship Award from the College on Problems of Drug Dependence during the organization’s annual conference in Montreal, June 17-22. The award, established in 2000, is given annually to a member of CPDD who has been an exemplary mentor to developing researchers in the field of drug dependence. In their commendation of Dr. Higgins, the award committee said they “admired the impressive caliber of scientists” he’d trained over the course of his career.  “We were especially impressed with the admiration and warm respect that were expressed in the supporting letters,” the committee explained.  “Your many contributions to the field of substance abuse research are deeply respected by the committee, as is your service to the College and its members. In short, we believe that you perfectly embody the ideals captured in the CPDD Mentorship Award.”

JAMA Psychiatry Publishes UVM TCORS Study on Reduced Nicotine Content Cigarettes in Vulnerable PopulationsJAMA-Psychiatry-Logo

Cigarette smoking is recognized as the number-one cause of preventable disease and death in the U.S., but it is one habit that is tough tobreak. The addictiveness of cigarettes is attributed to the nicotine content, which is a topic of high interest to the FDA. Research from the UVM's TCORS, led by Dr. Stephen Higgins, suggests that reducing the nicotine content in cigarettes may also decrease their addiction potential, especially in vulnerable populations. UVM has issued a press release with details on the study and access to the JAMA paper.

Within days of publication, this study has garnered coverage in several national and international media outlets, including MedPage Today, The Independent (UK), and New York Daily News.

Screen Shot 2017-10-18 at 12.06.48 PM

 
Click on image to read the VCBH Year in Review.